Drug intelligence / Profile preview

berberis vulgaris

Development stage
Phase 4
Modality
Small Molecules
Administration
Oral
01

Overview

**Berberis vulgaris** is a medicinal plant, commonly known as barberry, widely used in traditional medicine and as a food additive, especially in Iran[1][3]. All parts of the plant (fruit, bark, root, and stem) contain pharmacologically active compounds, including alkaloids such as berberine, oxyacanthine, and berbamine, as well as vitamins (notably vitamin C and vitamin K), triterpenoids, and phenolics[1]. The main mechanisms of action include anti-inflammatory and immunomodulatory effects via suppression of pro-inflammatory cytokines and induction of T regulatory cells, antioxidation, antihistaminic and anticholinergic effects, and possible calcium channel blockade[1][3]. The plant has demonstrated experimental efficacy in animal models and cell lines for conditions such as cancer, diabetes, hypertension, hyperlipidemia, bacterial infections, and pain[1][3]. In traditional medicine and homeopathy, it is used for kidney stone pain and various inflammatory conditions[2][4][6].

Other names
barberry
02

Targets

IL-6 (Interleukin 6)KCNH2 (Voltage-gated potassium channel subfamily H member 2)LTCC (Voltage-gated calcium channel (L-type))CaV3 (Caveolin-3)TNFA (Tumor necrosis factor alpha (soluble))AChR (Acetylcholine receptor)CaV (Voltage-gated calcium channel protein complex)H (Histamine receptors)

Beyond the preview

Go deeper on berberis vulgaris.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on berberis vulgaris.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call